Rafferty Asset Management
TARO

Rafferty Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Rafferty Asset Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,766
Closed -$236K – 858
2019
Q2 		$236K Buy
+2,766
New +$274K ﹤0.01% 767

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return

Rafferty Asset Management's TARO Position: Q3 2019 in Review

Rafferty Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2019, closing a stake of 2,766 shares — an estimated $236K sold.

Rafferty Asset Management first reported a position in TARO in Q2 2019 and held it in 1 quarter. The position peaked at $236K in Q2 2019. 101 funds tracked by Wall St. Rank hold TARO as of Q3 2019.

  • Rafferty Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2019 after selling out during the quarter.
  • Rafferty Asset Management sold 2,766 Taro Pharmaceutical Industries Ltd. shares in Q3 2019, an estimated $236K.
  • Rafferty Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2019 and held it in 1 quarter.
  • Rafferty Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $236K in Q2 2019.
  • 101 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2019.

Based on Rafferty Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.